Probiotics determine hypolipidemic and antioxidant effects in hyperlipidemic hamsters

Molecular Nutrition and Food Research

Volumn 58, Issue 3, 2014, Pages 559-568

  Stancu, Camelia Sorina ^a   Sanda, Gabriela Maria ^a   Deleanu, Mariana ^a   Sima, Anca Volumnia ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

Author keywords

Atherosclerosis; Hyperlipidemia; Lipoproteins; Oxidative stress; Probiotics

Indexed keywords

ANTIOXIDANT; CARRIER PROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; PROBIOTIC AGENT;

ANIMAL; BIFIDOBACTERIUM; BLOOD; DISEASE MODEL; DRUG EFFECTS; HEART MUSCLE; HYPERLIPIDEMIAS; LACTOBACILLUS ACIDOPHILUS; LIPID METABOLISM; LIVER; MALE; MESOCRICETUS; METABOLISM; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; BIFIDOBACTERIUM; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; HYPERLIPIDEMIAS; LACTOBACILLUS ACIDOPHILUS; LIPID METABOLISM; LIPIDS; LIPOPROTEINS, LDL; LIVER; MALE; MEMBRANE PROTEINS; MESOCRICETUS; MYOCARDIUM; OXIDATIVE STRESS; PROBIOTICS;

EID: 84897598085     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300224     Document Type: Article

References (49)

1. Perk, J., De Backer, G., Gohlke, H., Graham, I. et al., European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012, 223, 1-68.
2. Wang, C. C., Reusch, J. E., Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am. J. Cardiol. 2012, 110, 58B-68B.
3. Jiang, X. C., Goldberg, I. J., Park, T. S., Sphingolipids and cardiovascular diseases: lipoprotein metabolism, atherosclerosis and cardiomyopathy. Adv. Exp. Med. Biol. 2011, 721, 19-39.
4. Davidson, M. H., Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist. Am. J. Cardiol. 2012, 110, 43B-49B.
5. Nicholls, S. J., Tuzcu, E. M., Nissen, S. E., Atherosclerosis regression: is low-density lipoprotein or high-density lipoprotein the answer? Curr. Atheroscler. Rep. 2007, 9, 266-273.
6. Stephens, J. W., Khanolkar, M. P., Bain, S. C., The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis 2009, 202, 321-329.
7. Tsimikas, S., Miller, Y. I., Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr. Pharm. Des. 2011, 17, 27-37.
8. Stancu, C. S., Toma, L., Sima, A. V., Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell. Tissue Res. 2012, 349, 433-446.
9. Navab, M., Reddy, S. T., Van Lenten, B. J., Anantharamaiah, G. M. et al., The role of dysfunctional HDL in atherosclerosis. J. Lipid. Res. 2009, 50(Suppl), S145-S149.
10. Mackness, B., Mackness, M., The antioxidant properties of high-density lipoproteins in atherosclerosis. Panminerva Med. 2012, 54, 83-90.
11. Gotto, A. M., Jr., Moon, J. E., Recent clinical studies of the effects of lipid-modifying therapies. Am. J. Cardiol. 2012, 110, 15A-26A.
12. Elis, A., Lishner, M., Non-every day statin administration-a literature review. Eur. J. Intern. Med. 2012, 23, 474-478.
13. Deng, R., Food and food supplements with hypocholesterolemic effects. Recent Pat. Food Nutr. Agric. 2009, 1, 15-24.
14. Goto, T., Kim, Y. I., Takahashi, N., Kawada, T., Natural compounds regulate energy metabolism by the modulating the activity of lipid-sensing nuclear receptors. Mol. Nutr. Food Res. 2013, 57, 20-33.
15. Farbstein, D., Kozak-Blickstein, A., Levy, A. P., Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules 2010, 15, 8098-8110.
16. Tinkel, J., Hassanain, H., Khouri, S. J., Cardiovascular antioxidant therapy: a review of supplements, pharmacotherapies, and mechanisms. Cardiol. Rev. 2012, 20, 77-83.
17. Niki, E., Assessment of antioxidant capacity of natural products. Curr. Pharm. Biotechnol. 2010, 11, 801-809.
18. Scarpellini, E., Cazzato, A., Lauritano, C., Gabrielli, M. et al., Probiotics: which and when? Dig. Dis. 2008, 26, 175-182.
19. Ohland, C. L., Macnaughton, W. K., Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G807-G819.
20. Amit-Romach, E., Uni, Z., Reifen, R., Multistep mechanism of probiotic bacterium, the effect on innate immune system. Mol. Nutr. Food Res. 2010, 54, 277-284.
21. Gratz, S. W., Mykkanen, H., El-Nezami, H. S., Probiotics and gut health: a special focus on liver diseases. World J. Gastroenterol. 2010, 16, 403-410.
22. Musso, G., Gambino, R., Cassader, M., Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care 2010, 33, 2277-2284.
23. Tlaskalova-Hogenova, H., Stepankova, R., Kozakova, H., Hudcovic, T. et al., The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol. Immunol. 2011, 8, 110-120.
24. Pereira, D. I., Gibson, G. R., Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit. Rev. Biochem. Mol. Biol. 2002, 37, 259-281.
25. Paik, H. D., Park, J. S., Park, E., Effects of Bacillus polyfermenticus SCD on lipid and antioxidant metabolisms in rats fed a high-fat and high-cholesterol diet. Biol. Pharm. Bull. 2005, 28, 1270-1274.
26. Amaretti, A., di Nunzio, M., Pompei, A., Raimondi, S. et al., Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl. Microbiol. Biotechnol. 2013, 97, 809-817.
27. Sullivan, M. P., Cerda, J. J., Robbins, F. L., Burgin, C. W. et al., The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab. Anim. Sci. 1993, 43, 575-578.
28. Guyard-Dangremont, V., Desrumaux, C., Gambert, P., Lallemant, C. et al., Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1998, 120, 517-525.
29. Horton, J. D., Cuthbert, J. A., Spady, D. K., Regulation of hepatic 7 alpha-hydroxylase expression and response to dietary cholesterol in the rat and hamster. J. Biol. Chem. 1995, 270, 5381-5387.
30. Nistor, A., Bulla, A., Filip, D. A., Radu, A., The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 1987, 68, 159-173.
31. Sima, A., Bulla, A., Simionescu, N., Experimental obstructive coronary atherosclerosis in the hyperlipidemic hamster. J. Submicrosc. Cytol. Pathol. 1990, 22, 1-16.
32. Bhathena, J., Martoni, C., Kulamarva, A., Urbanska, A. M. et al., Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters. J. Med. Food 2009, 12, 310-319.
33. Kikuchi-Hayakawa, H., Onodera, N., Matsubara, S., Yasuda, E. et al., Effects of soya milk and Bifidobacterium-fermented soya milk on plasma and liver lipids, and faecal steroids in hamsters fed on a cholesterol-free or cholesterol-enriched diet. Br. J. Nutr. 1998, 79, 97-105.
34. Sanz, Y., Santacruz, A., Gauffin, P., Gut microbiota in obesity and metabolic disorders. Proc. Nutr. Soc. 2010, 69, 434-441.
35. Larach, D. B., deGoma, E. M., Rader, D. J., Targeting high density lipoproteins in the prevention of cardiovascular disease? Curr. Cardiol. Rep. 2012, 14, 684-691.
36. Huang, Y., Wu, F., Wang, X., Sui, Y. et al., Characterization of Lactobacillus plantarum Lp27 isolated from Tibetan kefir grains: a potential probiotic bacterium with cholesterol-lowering effects. J. Dairy Sci. 2013, 96, 2816-2825.
37. Usman, Hosono, A., Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J. Dairy Sci. 1999, 82, 243-248.
38. Reynier, M. O., Montet, J. C., Gerolami, A., Marteau, C. et al., Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J. Lipid Res. 1981, 22, 467-473.
39. Davidson, M. H., Therapies targeting exogenous cholesterol uptake: new insights and controversies. Curr. Atheroscler. Rep. 2011, 13, 95-100.
40. Bartelt, A., Merkel, M., Heeren, J., A new, powerful player in lipoprotein metabolism: brown adipose tissue. J. Mol. Med. (Berl.) 2012, 90, 887-893.
41. Hagberg, C. E., Falkevall, A., Wang, X., Larsson, E. et al., Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 2010, 464, 917-921.
42. Martarelli, D., Verdenelli, M. C., Scuri, S., Cocchioni, M. et al., Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training. Curr. Microbiol. 2011, 62, 1689-1696.
43. Shamir, R., Hartman, C., Karry, R., Pavlotzky, E. et al., Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic. Biol. Med. 2005, 39, 336-344.
44. Naruszewicz, M., Johansson, M. L., Zapolska-Downar, D., Bukowska, H., Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr. 2002, 76, 1249-1255.
45. Nordgaard, I., Mortensen, P. B., Digestive processes in the human colon. Nutrition 1995, 11, 37-45.
46. Nishina, P. M., Freedland, R. A., Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J. Nutr. 1990, 120, 668-673.
47. Cohen, G., Riahi, Y., Shamni, O., Guichardant, M. et al., Role of lipid peroxidation and PPAR-delta in amplifying glucose-stimulated insulin secretion. Diabetes 2011, 60, 2830-2842.
48. Zhang, Y., Xue, R., Zhang, Z., Yang, X. et al., Palmitic and linoleic acids induce ER stress and apoptosis in hepatoma cells. Lipids Health Dis. 2012, 11, 1-8.
49. Mugabo, Y., Mukaneza, Y., Renier, G., Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid-induced endothelial dysfunction. Metabolism 2011, 60, 640-648.